Tag: pharmaceuticals

  • Statins Found to Reduce Cancers After Heart Transplants

    A study by physicians and medical researchers at University Hospital Zurich in Switzerland indicates heart transplant patients taking statins — drugs used to lower cholesterol — reduced their risk of getting cancer, and were associated with overall survival independent of their cholesterol levels. The findings were reported yesterday at a meeting of the European Society…

  • Study: FDA Approves Drugs Faster Than in Europe, Canada

    Researchers at the Yale University medical school have found that since 2001, the U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe. The findings of medical student Nicholas Downing and colleagues appear online in the New England Journal of Medicine. Downing’s team, under the…

  • U.S. Patent Awarded for Synthetic Hepatitis C Biocatalysts

    The U.S. Patent and Trademark Office awarded yesterday a patent covering biocatalysts and biocatalytic processes used to make intermediate products in the synthesis of hepatitis C drugs. Patent number 8,178,333 was awarded to 13 inventors and assigned to Codexis Inc. in Redwood City, California. Codexis is a biotechnology company that develops and markets engineered enzymes…

  • NIH Grant Awarded for Smoking Relapse Prevention Drug

    National Institute on Drug Abuse, part of the National Institutes of Health (NIH), has awarded Scripps Research Institute in Jupiter, Florida a grant to develop drugs that help prevent relapse in smokers who are kicking the habit. The five-year $8.4 million grant will support a team led by Scripps researcher Paul Kenny (pictured right). Scripps…

  • Stem Cells Found to Protect Against Chemo Side Effects

    Researchers at the Fred Hutchinson Cancer Research Center in Seattle and four other institutions have developed a method for transplanting brain cancer patients’ own gene-modified blood stem cells to protect their bone marrow against the toxic side effects of chemotherapy. Their findings appear in this week’s issue of the journal Science Translational Medicine (paid subscription…

  • Cancer Stem Cell Drug Screening Chip Developed

    Researchers at the Institute of Bioengineering and Nanotechnology (IBN) in Singapore have developed a miniaturized biochip for investigating the effect of drugs on cancer stem cells. The findings of the team led by IBN executive director Jackie Ying appears the journal Nano Today, and the technology is being commercialized by a spin-off company from the…

  • Biotech Lands $20M Series A Funds for Protein Therapies

    Eleven Biotherapeutics in Cambridge, Massachusetts has secured an additional $20 million in series A funds, the first round of investment financing after initial start-up. A new investor, JAFCO Company Ltd in Tokyo, joins existing investors Third Rock Ventures and Flagship Ventures in the deal. Eleven Biotherapeutics is expected to use the proceeds from the financing…

  • Early Trial Results Indicate Cystic Fibrosis Drug Efficacy

    Vertex Pharmaceuticals Inc. in Cambridge, Massachusetts says interim data from a clinical trial of its cystic fibrosis drugs point to improved lung function among patients who took the drugs. The results reported from the trial were for patients with two copies of the most common mutation of the cystic fibrosis regulator gene. The phase 2…

  • Genomic Test Developed for ADHD Drug Decisions

    AssureRx Health Inc. in Mason, Ohio has developed a test to help clinicians prescribe the appropriate medications for patients — both children and adults — with attention deficit hyperactivity disorder (ADHD). The test, called GeneSightRx ADHD, gauges genomic differences in the way different patients would tolerate ADHD medications. Understanding a patient’s unique genomic composition may…

  • Engineered Nanoparticles Target Drug-Resistant Bacteria

    Researchers at Massachusetts Institute of Technology, Harvard University, and Brigham and Women’s Hospital in Boston have developed nanoscale particles that can deliver antibiotics in larger quantities, but directly to the targeted bacteria to overcome drug resistance. The findings of the engineering, computer science, and health sciences team appear online in the journal ACS Nano (paid…